Peptide receptor imaging: Advances in the diagnosis of pulmonary diseases

American Journal of Respiratory Medicine

Volumn 1, Issue 3, 2002, Pages 177-183

  Van de Wiele, Christophe ^a   Signore, Alberto ^b   Dierckx, Rudi Andre ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; BITISTATIN; BOMBESIN DERIVATIVE; CD11B ANTIGEN; CD14 ANTIGEN; CELL SURFACE RECEPTOR; CHOLECYSTOKININ B RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GALACTOSIDE; GASTRIN RELEASING PEPTIDE; IMMUNOGLOBULIN; INDIUM 111; IODINE 123; LIPOPOLYSACCHARIDE; MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY; OCTREOTIDE; ONCOPROTEIN; PENTETIC ACID; PEPTIDE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; TECHNETIUM 99M; TRASTUZUMAB; TYROSINE KINASE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ACUTE DISEASE; ACYLATION; BINDING AFFINITY; CHRONIC DISEASE; CYTOMEGALOVIRUS; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG APPROVAL; DRUG ISOLATION; DRUG RECEPTOR BINDING; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOTOPE LABELING; KLEBSIELLA PNEUMONIAE; LEG THROMBOSIS; LUNG CANCER; LUNG DISEASE; LUNG EMBOLISM; LUNG INFECTION; LUNG NODULE; LUNG SCINTISCANNING; LYMPHOCYTE ACTIVATION; MACROPHAGE; MICROBIAL IDENTIFICATION; MONOCYTE; MYCOBACTERIUM AVIUM; MYCOSIS; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; THROMBOCYTE ACTIVATION; VEIN THROMBOSIS;

EID: 0042887677     PISSN: 11756365     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03256607     Document Type: Review

References (62)

1. Signore A, Annovazzi A, Chianelli M, et al. Peptide radiopharmaceuticals for diagnosis and therapy. Eur J Nucl Med 2001; 28: 1555-65
2. Liu S, Edwards DS. 99mTc-labelled small peptides as diagnostic radiopharmaceuticals. Chem Rev 1999; 9: 2235-68
3. Behr TM, Gotthardt M, Becker W, et al. Radioiodination of monoclonal antibodies, proteins and peptides for diagnosis and therapy: a review of standardized, reliable and safe procedures for clinical grade levels kBq to GBq in the Gottingen/Marburg Experience. Nuklearmedizin 2002; 41: 71-9
4. Behr TM, Gotthardt M, Barth A, et al. Imaging tumors with peptide-based radiopharmaceuticals. Q J Nucl Med 2001; 45: 189-200
5. Kelley MJ, Johnson BE. Molecular biology of lung cancer. In: Mendelsohn J, Howley PM, Israel MA, et al., editors. The molecular basis of cancer. Philadelphia (PA): Saunders, 2001: 260-72
6. Moody TW, Cuttita F. Growth-factor and peptide receptors in small-cell lung cancer. Life Sci 1993; 52: 1161-73
7. Moody TW. Peptides and growth factors in non-small cell lung cancer. Peptides 1996; 17: 545-55
8. Ardizzonni A, Grossi F, Meazza R, et al. New perspectives for the pharmacological and biological therapy of small cell lung cancer. Crit Rev Oncol Hematol 1999; 31: 135-45
9. Frei E. Non-small cell lung cancer: novel treatment strategies. Chest 1997; 4 Suppl.: 266-8
10. Spindel ER, Nagalla S, Barry B. Bombesin-related peptides. U.S. Patent 1995, 5,410,018
11. McDonald TJ, Jornvall H, Nilsson G, et al. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun 1979; 90: 227-33
12. Van de Wiele C, Dumont F, Van Belle S, et al. Is there a role for agonist gastrin releasing peptide receptor radioligands in turnout imaging? Nucl Med Commun 2001; 1: 5-15
13. ToiScott M, Jones CL, Kane MA. Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells. Lung Cancer 1996; 15 (3): 341-54
14. Reubi JC, Waser B, Laderach U, et al. Localization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach. Gastroenterology 1997; 112: 1197-205
15. Reubi JC, Schaer JC, Waser B. Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res 1997; 57: 1377-86
16. Behr TM, Behe M, Angerstein C, et al. CholecystokininB/gastrin receptors binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Clin Cancer Res 1999; 10 Suppl.: 3124-38
17. de Jong M, Bakker WH, Bernard BF, et al. Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analogue: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy. J Nucl Med 1999; 40: 2081-7
18. Behr TM, Jenner N, Behe M, et al. Radiolabelled peptides for targeting cholecystokinin-B/gastrin receptor expressing tumors. J Nucl Med 1999; 40: 1029-44
19. O'Byrne KJ, Schally AV, Thomas A, et al. Somatostatin, its receptors and analogs, in lung cancer. Chemotherapy, 2001; 47: 78-108
20. Reisinger I, Bohuslavitzki KH, Brenner W, et al. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study. J Nucl Med 1998; 39: 224-7
21. Hochenstenbag MMH, Heidendal GAK, Wouters EFM, et al. In-111 octreotide imaging in small cell lung cancer. Clin Nucl Med 1997; 22: 811-6
22. Buccheri G, Ferrigno D, Biggi A. Nuclear medicine in lung cancer: a plenty of possibilities. Int J Oncol 1997; 10: 847-55
23. Kwekkeboom DJ, Kho GS, Lamberts SWJ, et al. The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994; 10: 1106-13
24. Stokkel MPM, Kwa BM, Pauwels EJK. Imaging and staging of small cell lung cancer: is there a role for octreotide scintigraphy. Br J Clin Pract 1995; 49: 235-8
25. Blum J, Handmaker H, Lister-James J, et al. A multicentre trial with somatostatin analog Tc-99m depreotide in the evaluation of solitary pulmonary nodules. Chest 2000; 117: 1232-8
26. Busto R, Prieto JC, Bodega G, et al. Immunohistochemical localization and distribution of VIP/PACAP receptors in human lung. Peptides 2000; 21: 265-9
27. Reubi JC. In-vitro identification of vasoactive-intestinal-peptide receptors in human tumors-implications for tumor imaging. J Nucl Med 1995; 36: 1846-53
28. Raderer M, Kurturan A, Hejna M, et al. I-123-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer. Br J Cancer 1998; 78: 1-5
29. Virgolini I. Mack Forster Award Lecture -Receptor nuclear medicine: vasointestinal peptide and somatostatin receptor scintigraphy for diagnosis and treatment of tumour patients. Eur J Clin Invest 1997; 27: 793-800
30. Raderer M, Kurturan A. Yang Q, et al. Iodine-123-vasoactive intestinal peptide receptor scanning in patients with pancreatic cancer. J Nucl Med 1998; 39: 1570-5
31. Virgolini I, Raderer M, Kurturan A, et al. I-123-vasoactive intestinal peptide (VIP) receptor scanning: update of imaging results in patients with adenocarcinomas and endocrine tumours of the gastrointestinal tract. Nucl Med Biol 1996; 23: 685-92
32. Thakur ML, Marcus CS, Saeed S, et al. 99mTc-labeled vasoactive intestinal peptide analog for rapid localization of tumors in humans. J Nucl Med 2000; 41: 107-10
33. Brabender J, Danenberg KD, Metzger R, et al. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival. Clin Cancer Res 2001; 7: 1850-5
34. Ramos-Suzarte M, Rodriguez N, Olivia JP, et al. Tc-99m-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: part III. Clinical trials, safety and diagnostic efficacy. J Nucl Med 1999; 40: 768-75
35. Dadparvar S, Krishna L, Miyamoto C, et al. Indium-111-labeled anti-EGFR-425 scintigraphy in the detection of malignant gliomas. Cancer 1994; 73: 884-9
36. Senekowitsch Schmidtke R, Steiner K, Haunschild J, et al. In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumour xenografts using radiolabeled EGF and anti-(EGF receptor) mAB 425. Cancer Immunol Immunother 1996; 42: 108-14
37. Pateisky N, Schatten C, Vavra N, et al. Lymphoscintigraphy using epidermal growth-factor as tumor-seeking agent in uterine cervical cancer. Wien Klin Wochenschr 1991; 103: 654-6
38. Reilly RM, Kiarash R, Cameron R, et al. In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. J Nucl Med 2000; 41: 429-38
39. Scholl S, Beuzeboc P, Pouillart P. Targeting HER2 in other tumor types. Ann Oncol 2001; 12 Suppl.: 81-7
40. Behr TM, Behe M, Wormann B. Trastuzumab and breast cancer. N Engl J Med 2001; 345: 995-6
41. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990; 236: 2753-9
42. Blum J. Receptor radiopharmaceuticals: biomolecular medicine. Eur J Nucl Med 2000; 27: 121-2
43. Missy K, Giuriato S, Bodin S, et al. Integrins and signal transduction: illustration with the alpha(IIb)beta(3) integrin in platelets. Med Sci 2001; 17: 155-61
44. Taillefer R, Edell S, Innes G, et al. Acute thromboscintigraphy with Tc-99m-apcitide: results of the phase 3 multicentre clinical trial comparing Tc-99m-apcitide scintigraphy with contrast venography for imaging acute DVT. J Nucl Med 2000; 41: 1214-23
45. Lister-James J, Moyer BR, Dean RT. Pharmacokinetic considerations in the development of peptide-based imaging agents. Q J Nucl Med 1997; 41: 111-8
46. Pallela V, Consigny PM, Shi R, et al. Imaging vascular thrombosis with Tc-99-TP-1300 peptide derived from active domain of thrombospondin (TSP) [abstract]. J Nucl Med 1998; 39: 64P
47. Knight LC, Radcliffe R, Maurer AH, et al. Thrombus imaging with Tc-99m synthetic peptides based upon the binding domain of a monoclonal-antibody to activated platelets. J Nucl Med 1994; 35: 282-8
48. Knight LC, Baidoo KE, Romano JE, et al. Imaging pulmonary emboli and deep venous thrombi with 99mTc-bitistatin, a platelet-binding polypeptide from viper venom. J Nucl Med 2000; 41: 1056-64
49. Barrett JA, Crocker A, Hemingway S, et al. DMP444, a technetium-labelled platelet GPIIb/IIIa antagonist for the detection of arterial thrombi [abstract]. J Nucl Med 1997; 38: 18P
50. Boerman O, Oyen WJG, Corstens FHM. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals. Semin Nucl Med 2000; 30 (3): 195-208
51. Buscombe JR, Oyen WJ, Grant A, et al. Indium-111-labeled polyclonal human immunoglobulin: identifying focal infection in patients positive for human immunodeficiency virus. J Nucl Med 1993; 34: 1621-5
52. Buscombe JR, Khalkhali I, Mason GR, et al. Indium-111 labelled pooled human immunoglobulin imaging to monitor the efficacy of specific therapy for Pneumocystis carinii pneumonia. Eur J Nucl Med 1994; 21: 1148-50
53. Buscombe JR, Oyen WJ, Corstens FH, et al. A comparison of 111In-HIG scintigraphy and chest radiology in the identification of pulmonary infection in patients with HIV infection. Nucl Med Commun 1995; 16: 327-35
54. Buscombe JR, Oyen WJ, Corstens FH. Use of polyclonal IgG in HIV infection and AIDS. J Nucl Med 1995; 39: 212-20
55. Calame W, Welling M, Feitsma HI, et al. Contribution of phagocytic cells and bacteria to the accumulation of technetium-99m labelled polyclonal human immunoglobulin at sites of inflammation. Eur J Nucl Med 1995; 22: 638-44
56. Morrel EM, Tompkins RG, Fischman AH, et al. Autoradiographic method for quantitation of radiolabelled proteins in tissues using indium-111. J Nucl Med 1989; 30: 1538-45
57. Fischman AJ, Rubin RH, White JA, et al. Localization of Fc, and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. J Nucl Med 1990; 31: 1199-205
58. Diot P, LePape A, Nolibe D, et al. Scintigraphy with J001X, a Klebsiella membrane glycolipid, for the early diagnosis of chronic berilliosis: results from an experimental model. Br J Ind Med 1992; 49: 359-64
59. Diot P, Diot E, Lemarie E, et al. Imaging of pulmonary disease in scleroderma with J001X scintigraphy. Thorax 1994; 49: 504-8
60. Goupille P, Diot P, Valat JP, et al. Imaging of pulmonary disease in rheumatoid arthritis using J001X scintigraphy: preliminary results. Eur J Nucl Med 1995; 22: 1411-5
61. Kwekkeboom DJ, Krenning EP, Kho GS, et al. Somatostatin receptor imaging in patients with sarcoidosis. Eur J Nucl Med 1998; 25: 1284-92
62. Van Hagen P, Krenning E, Reubi J, et al. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med 1994; 21: 497-502